# Arbutus Biopharma Corp: Form 20-F for the period ended Dec 31, 2011

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 20-F
- Filed: 2012-03-27
- Accepted by EDGAR: Mar 27, 2012, 17:28 ET
- Period: 2011-12-31
- Accession: 0001193125-12-134709
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000119312512134709/d320832d20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000119312512134709/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Shares outstanding | at 2011-12-31 | 12,148,636 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000119312512134709/d320832d20f.htm

Filed Mar 27, 2012.
Source: SEC EDGAR, the filing index for accession 0001193125-12-134709. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
